|The fungal exopolysaccharide galactosaminogalactan mediates virulence by enhancing resistance to neutrophil extracellular traps|
MJ Lee, H Liu, BM Barker, BD Snarr, FN Gravelat, Q Al Abdallah, ...
PLoS pathogens 11 (10), e1005187, 2015
|Microbial glycoside hydrolases as antibiofilm agents with cross-kingdom activity|
BD Snarr, P Baker, NC Bamford, Y Sato, H Liu, M Lehoux, FN Gravelat, ...
Proceedings of the National Academy of Sciences 114 (27), 7124-7129, 2017
|Posaconazole-loaded leukocytes as a novel treatment strategy targeting invasive pulmonary aspergillosis|
SR Baistrocchi, MJ Lee, M Lehoux, B Ralph, BD Snarr, R Robitaille, ...
The Journal of infectious diseases 215 (11), 1734-1741, 2017
|Beyond tissue concentrations: antifungal penetration at the site of infection|
Y Zhao, B Prideaux, S Baistrocchi, DC Sheppard, DS Perlin
Medical mycology 57 (Supplement_2), S161-S167, 2019
|Galectin-3 enhances neutrophil motility and extravasation into the airways during Aspergillus fumigatus infection|
BD Snarr, G St-Pierre, B Ralph, M Lehoux, Y Sato, A Rancourt, ...
PLoS pathogens 16 (8), e1008741, 2020
|Supervised exercise for cardiovascular rehabilitation—the Limerick programme|
R O’Connor, R Power, K Bissett, KA Bourdan, K Togher, H Power, ...
Irish Journal of Medical Science (1971-) 189 (1), 403-404, 2020
|In vivo pharmacokinetics and pharmacodynamics of posaconazole in a mouse model of invasive aspergillosis|
SR Baistrocchi, H Liu, RJM Bruggeman, WW Hope, S Filler, DC Sheppard
MYCOSES 60, 221-222, 2017
|Strategies to Optimize the Effectiveness of Antifungal Treatment for Invasive Aspergillosis|
D Sheppard, J Fricker, S Baistrocchi
Anti-Infective Agents 15 (1), 20-24, 2017